U.S. Physical Therapy, Inc. (UPH.F)
- Previous Close
95.50 - Open
95.50 - Bid 93.50 x 50000
- Ask 94.50 x 50000
- Day's Range
95.50 - 95.50 - 52 Week Range
75.50 - 111.00 - Volume
10 - Avg. Volume
0 - Market Cap (intraday)
1.401B - Beta (5Y Monthly) 1.38
- PE Ratio (TTM)
78.15 - EPS (TTM)
1.19 - Earnings Date May 7, 2024
- Forward Dividend & Yield 1.62 (1.70%)
- Ex-Dividend Date Mar 11, 2024
- 1y Target Est
133.25
U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.
www.usph.com3,899
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: UPH.F
Performance Overview: UPH.F
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: UPH.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: UPH.F
Valuation Measures
Market Cap
1.41B
Enterprise Value
1.51B
Trailing P/E
79.83
Forward P/E
39.68
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.40
Price/Book (mrq)
3.23
Enterprise Value/Revenue
2.50
Enterprise Value/EBITDA
20.34
Financial Highlights
Profitability and Income Statement
Profit Margin
4.72%
Return on Assets (ttm)
4.69%
Return on Equity (ttm)
6.55%
Revenue (ttm)
598.63M
Net Income Avi to Common (ttm)
18.14M
Diluted EPS (ttm)
1.19
Balance Sheet and Cash Flow
Total Cash (mrq)
155.49M
Total Debt/Equity (mrq)
39.65%
Levered Free Cash Flow (ttm)
65.97M
Research Analysis: UPH.F
Company Insights: UPH.F
UPH.F does not have Company Insights